Asbestos Lung Burden Does Not Predict Survival in Malignant Pleural Mesothelioma: A Necropsy-Based Study of 185 Cases

Pietro Gino Barbieri1, Dario Consonni2, Anna Somigliana3

  • 1Retired from Occupational Health Unit, Local Health Authority and Mesothelioma Registry of Brescia, Brescia, Italy.

Abstract

Insights

This study found no link between asbestos lung burden and survival in mesothelioma patients. Histologic subtype, not fiber count, is the key factor for prognosis in this asbestos-related disease.

Area of Science:

  • Occupational Medicine
  • Pathology
  • Environmental Health

Background:

  • Malignant pleural mesothelioma is an asbestos-related cancer with poor prognosis.
  • Histologic subtype is a known prognostic factor.
  • Previous studies suggested a link between asbestos lung burden and survival, but lacked a biological basis.

Purpose of the Study:

  • To investigate the relationship between asbestos lung burden and survival in patients with malignant pleural mesothelioma.
  • To determine if asbestos fiber count in lung tissue is a prognostic indicator.

Main Methods:

  • Analysis of 185 necropsies from Brescia and Monfalcone, Italy.
  • Quantification of asbestos fibers and bodies in lung tissue using microscopy.
  • Multivariable Cox regression models to assess survival based on asbestos fiber burden, adjusted for clinical factors.

Main Results:

  • No significant relationship was observed between asbestos lung burden and survival in either study group.
  • Median survival was 8.3 months in Brescia and 10.2 months in Monfalcone, despite higher lung burden in Monfalcone.
  • Hazard ratios for medium and high asbestos fiber burdens did not indicate increased mortality risk.

Conclusions:

  • Asbestos lung burden is not a significant prognostic determinant for malignant pleural mesothelioma.
  • Histologic subtype remains the most critical factor influencing patient survival.